Publications

Technology Status Evaluation Reports

Technology status evaluation reports provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Reports are based on an evaluation of medical literature and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided. Technology status evaluation reports are scientific reviews based on expert consensus and are provided solely for educational and informational purposes.

The members of the 91ÊÓƵTechnology Committee provide ongoing conflict of interest (COI) disclosures throughout the development and publication of all documents in accordance with the 91ÊÓƵPolicy for Managing Declared Conflicts of Interests.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published

  • Gastrointest Endosc 2025; Volume 101, Issue 3; P496-510 DOI: 10.1016/j.gie.2024.06.038

  • Gastrointest Endosc 2024; Volume 100, Issue 6; P980-993 DOI: 10.1016/j.gie.2024.05.004

  • Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002

  • iGIE 2023; Volume 2, Issue 3; P386-394

  • iGIE 2023; Volume 2, Issue 2; P226-239

  • iGIE 2023; Volume 2, Issue 2; P240-253

  • iGIE 2023; Volume 2, Issue 2; P254-261
Upper Endoscopy
All assessments
RETs
PIVIs

  • Gastrointest Endosc 2025; Volume 101, Issue 3; P496-510 DOI: 10.1016/j.gie.2024.06.038

  • Gastrointest Endosc 2024; Volume 100, Issue 6; P980-993 DOI: 10.1016/j.gie.2024.05.004

  • Video GIE 2022; Volume 7, Issue 1; P1-20

  • Gastrointest Endosc 2021; Volume 94, Issue 4; P671-684

  • Gastrointest Endosc 2021; Volume 94, Issue 1; P3-13

  • Video GIE 2020; Volume 5, Issue 12; P598-613

  • Gastrointest Endosc Sept 2020, Volume 92, Issue 3, Pages 483-491 / DOI:

  • GIE 2019; Volume 90, Issue 3; P325-334

  • Gastrointest Endosc July 2019 Volume 90, Issue 1, Pages 27–34

  • Gastrointest Endosc July 2019 Volume 90, Issue 1, Pages 13–26

  • Endoscopic anti-reflux devices (with videos) 2017

    Gastrointest Endosc 2017; Volume 86, Issue 6; P931-948

  • Gastrointest Endosc 2016;83:1051–1060

  • Gastrointest Endosc 2016;83:684–698.e7

  • Gastrointest Endosc 2015;82:215–226

  • Gastrointest Endosc 2015;82:975-990

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
Colonoscopy
All assessments
PIVIs

  • Gastrointest Endosc 2021; Volume 94, Issue 1; P1-2

  • Volume 92, Issue 3, Pages 474-482

  • Gastrointest Endosc March 2018 Volume 87, Issue 3, Pages 625–634

  • Gastrointest Endosc 2015;81:1122–1129

  • Gastrointest Endosc 2015;81:502.e1–502.e16

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
Bariatric Endoscopy
All assessments
RETs
PIVIs

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
ERCP

  • VideoGIE 2018;3:329-338

  • Gastrointest Endosc 2016;84:209–221

  • Gastrointest Endosc 2016;83:1061–1075
EUS
All assessments
RETs

  • Gastrointest Endosc 2021; Volume 94, Issue 4; P671-684

  • Gastrointest Endosc 2021; Volume 93, Issue 2; P323-333

  • VideoGIE 2017;2:35–45

  • Gastrointest Endosc May 2017, Volume 85, Issue 5, Pages 883–888

  • Gastrointest Endosc 2017;85:465–481

  • Gastrointest Endosc 2015;82:189–202

91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015

Nov 15, 2016, 19:12
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric therapies (EBTs) provide an effective and minimally invasive treatment approach to obesity that would increase treatment options beyond surgery, medications, and lifestyle measures. This systematic review and meta-analysis were performed by the American Society for Gastrointestinal Endoscopy (ASGE) Bariatric Endoscopy Task Force comprising experts in the subject area and the 91ÊÓƵTechnology Committee Chair to specifically assess whether acceptable performance thresholds outlined by an 91ÊÓƵPreservation and Incorporation of Valuable endoscopic Innovations (PIVI) document for clinical adoption of available EBTs have been met. After conducting a comprehensive search of several English-language databases, we performed direct meta-analyses by using random-effects models to assess whether the Orbera intragastric balloon (IGB) (Apollo Endosurgery, Austin, Tex) and the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) (GI Dynamics, Lexington, Mass) have met the PIVI thresholds.
Title : 91ÊÓƵBariatric Endoscopy Task Force systematic review and meta-analysis assessing the 91ÊÓƵPIVI thresholds for adopting endoscopic bariatric therapies 2015
URL : /docs/default-source/importfiles/Publications/Technology_Reviews/bariatrics-pivi-metaanalysis_aip.pdf?Status=Master&sfvrsn=0
Doi org link : http://dx.doi.org/10.1016/j.gie.2015.03.1964
Volume : Gastrointest Endosc 2015;82:425–438.e5
Select a choice : Keep
Content created : Jul 29, 2015, 05:30
ExternalPK : 18281
File size :
Categories :
  • Bariatrics
  • Gastrointestinal Endoscopy Journal
  • Stomach
  • Technical Reviews
  • Techniques
Tags :
  • BE PIVI
Bariatrics PIVI metaanalysis_AIP
Endoscope Design/Reprocessing
All assessments 
RETs

  • iGIE 2023; Volume 2, Issue 3; P386-394

  • iGIE 2023; Volume 2, Issue 2; P240-253

  • Gastrointest Endosc 2021; Volume 94, Issue 3; P457-470

  • Gastrointest Endosc 2021; Volume 93, Issue 5; P997-1005

  • GIE 2019; Volume 90, Issue 1; P1-12

  • Gastrointest Endosc 2016;84:885–892

  • Gastrointest Endosc 2016;83:857–865

  • iGIE 2023; Volume 2, Issue 3; P386-394

  • iGIE 2023; Volume 2, Issue 2; P240-253

  • Gastrointest Endosc 2021; Volume 93, Issue 5; P997-1005
Other Imaging Techniques
All assessments
RETs

  • Gastrointest Endosc 2021; Volume 93, Issue 4; P784-796

  • Gastrointest Endosc 2015;81:249–261
Therapeutic GI Devices
All assessments
RETs

  • iGIE 2023; Volume 2, Issue 2; P226-239

  • Video GIE 2019; Volume 4, Issue 8; P343-350

  • Video GIE 2019; Volume 4, Issue 7; P285-299

  • VideoGIE October 2017 Volume 2, Issue 10, Pages 252–259

  • VideoGIE May 2017, Volume 2, Issue 5, Pages 89–95

  • Gastrointest Endosc 2015;81:1311–1325

  • iGIE 2023; Volume 2, Issue 2; P226-239
Miscellaneous
All assessments
RETs

Submucosal injection fluid and tattoo agents 2024

Nov 5, 2024, 11:24
Title : Submucosal injection fluid and tattoo agents 2024
URL :
Doi org link : https://www.giejournal.org/article/S0016-5107(24)03347-9/fulltext
Volume : Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002
Select a choice : Keep
Content created :
ExternalPK :
File size :
Categories :
Tags :
  • misc

  • Gastrointest Endosc 2024; Volume 100, Issue 5; p797-806 DOI: 10.1016/j.gie.2024.07.002

  • iGIE 2023; Volume 2, Issue 2; P254-261

In Progress Technology Assessments

Endoscopic closure devices

2025

iStock-1189305225(1)

Practice Guidelines

View all